10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 115,842 | 105,821 | 112,218 | 71,817 | 42,905 |
| Cost of Goods | 4,915 | 17,060 | 18,897 | 14,411 | 10,052 |
| Gross Profit | 110,927 | 88,761 | 93,321 | 57,406 | 32,853 |
| Operating Expenses | 122,170 | 99,037 | 503,801 | 123,072 | 72,325 |
| Operating Income | -10,328 | -10,216 | -409,583 | -65,255 | -39,420 |
| Interest Expense | 209 | 221 | 317 | 397 | 306 |
| Other Income | 579 | -679 | 1,277 | 389 | -19 |
| Pre-tax Income | -9,958 | -11,116 | -408,623 | -65,263 | -39,745 |
| Income Tax | 1,094 | 435 | 6,950 | 585 | 422 |
| Net Income Continuous | -11,052 | -11,551 | -415,573 | -65,848 | -40,167 |
| Net Income | $-11,052 | $-11,551 | $-415,573 | $-65,848 | $-40,167 |
| EPS Basic Total Ops | -0.10 | -0.11 | -4.09 | -0.65 | -0.41 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -4.09 | -0.65 | -0.41 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -4.09 | -0.65 | -0.41 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -4.09 | -0.65 | -0.41 |
| EBITDA(a) | $-3,141 | $-3,748 | $-404,167 | $-60,378 | $-34,952 |